63 related articles for article (PubMed ID: 8926680)
1. [Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogenic bone marrow transplantation].
Körholz D; Hempel L; Packeisen J; Kunst D; Zintl F; Burdach S
Klin Padiatr; 1996; 208(4):141-4. PubMed ID: 8926680
[TBL] [Abstract][Full Text] [Related]
2. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunodeficiency in patients after bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Mauz-Körholz C; Zintl F; Burdach S
Bone Marrow Transplant; 1996 Dec; 18(6):1123-30. PubMed ID: 8971382
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
Yabe M; Yabe H; Hattori K; Shimizu T; Matsumoto M; Morimoto T; Yasuda Y; Inoue H; Kato S; Nishimura T
Bone Marrow Transplant; 1999 Jul; 24(1):29-34. PubMed ID: 10435731
[TBL] [Abstract][Full Text] [Related]
6. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
[TBL] [Abstract][Full Text] [Related]
7. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation.
Hempel L; Körholz D; Nussbaum P; Bönig H; Burdach S; Zintl F
Bone Marrow Transplant; 1997 Sep; 20(5):365-8. PubMed ID: 9339750
[TBL] [Abstract][Full Text] [Related]
8. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
Remberger M; Ringden O; Markling L
Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
12. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Reddy V; Winer AG; Eksioglu E; Meier-Kriesche HU; Schold JD; Wingard JR
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1014-21. PubMed ID: 16338624
[TBL] [Abstract][Full Text] [Related]
14. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
15. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
[TBL] [Abstract][Full Text] [Related]
16. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
17. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
18. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
19. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
20. Correlation of low histidine rich glycoprotein plasma levels with the occurrence of acute graft-versus-host disease after allogeneic bone marrow transplantation.
Mauz-Körholz C; Körholz D; Burdach S
J Lab Clin Med; 1995 Aug; 126(2):144-50. PubMed ID: 7636387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
